Long non-coding RNA <i>FEZF1-AS1</i> facilitates cell proliferation and migration in colorectal carcinoma

Na Chen, Dan Guo, Qiong Xu, Minhui Yang, Dan Wang, Man Peng, Yanqing Ding, Shuang Wang, Jun Zhou

Oncotarget · 2016 · 100 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

// Na Chen 1, 2, * , Dan Guo 3, * , Qiong Xu 1, 2 , Minhui Yang 1, 2 , Dan Wang 1 , Man Peng 1 , Yanqing Ding 2 , Shuang Wang 1, 2 , Jun Zhou 1, 2 1 Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China 2 Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China 3 Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China * These authors contributed equally to this work Correspondence to: Jun Zhou, e-mail: jzhou16@163.com Shuang Wang, e-mail: shuangw@126.com Keywords: FEZF1-AS1, FEZF1, colorectal cancer, long non-coding RNA Received: July 16, 2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accepted: January 21, 2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Published: February 03, 2016 ABSTRACT Long non-coding RNAs (lncRNA) have been shown to play important roles in the development and progression of cancer. Here, we discovered a novel long noncoding RNA (lncRNA) FEZF1 antisense RNA1 ( FEZF1-AS1 ) is markedly upregulated in human primary colorectal carcinoma (CRC) and associated with CRC metastasis and poor prognosis. Moreover, the downregulation of FEZF1-AS1 expression significantly inhibited the CRC cells proliferation, migration and invasiveness, suppressed S-phase entry in vitro , and repressed tumor growth and metastasis in vivo . In contrast, overexpression of FEZF1-AS1 could promote the aggressive behaviors of CRC cells. We further discovered that the downregulation of FEZF1-AS1 reduced its sense-cognate gene FEZF1 mRNA and protein expression in CRC cells. There was a positive correlation between FEZF1-AS1 and FEZF1 expression in CRC. Moreover, FEZF1 knockdown also significantly suppressed CRC cell proliferation, migration, and invasion. Our findings indicate that the dysregulation of FEZF1-AS1 participates in colorectal tumorigenesis and progression, which might be achieved, at least in part, through FEZF1 induction.

References

30